Published
MedCheck: FDA Approves Novel Antipsychotic Milsaperidone; Designates Psilocybin Analogue as Breakthrough Therapy for Postpartum Depression, and More!
No abstract availability was recorded for this entry.
No abstract availability was recorded for this entry.
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
No close related records were found yet.